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Abstract
Healthy individuals of African ancestry have neutropenia that has been linked with the variant 
rs2814778(G) of the gene encoding atypical chemokine receptor 1 (ACKR1). This polymorphism 
selectively abolishes the erythroid cell expression of ACKR1, causing Duffy-negative phenotype. 
Here we describe an unexpected fundamental role that ACKR1 plays in hematopoiesis and provide 
the mechanism linking its absence with neutropenia. Nucleated erythroid cells highly expressed 
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ACKR1, which facilitated their direct contacts with the hematopoietic stem cells. The absence of 
erythroid ACKR1 altered murine hematopoiesis, including stem and progenitor cells, ultimately 
giving rise to phenotypically distinct neutrophils, which readily left the circulation, causing 
neutropenia. Duffy-negative individuals developed a distinct profile of neutrophil effector 
molecules closely reflecting that in the ACKR1-deficient mice. Thus, alternative physiological 
patterns of hematopoiesis and bone marrow cell outputs depend on the expression of ACKR1 in 
the erythroid lineage providing major implications for the selection advantages that have resulted 
in the paramount fixation of the rs2814778(G) polymorphism in Africa.
Introduction
Chemokines comprise a family of structurally homologous, intercellular molecular signals 
that induce migration and other cellular responses, including adhesion, activation, 
differentiation, proliferation and survival1–4. Chemokine effects are mediated by classical 
G-protein coupled receptors (GPCRs)1,2. Additionally, chemokines ligate atypical 
chemokine receptors (ACKRs)5,6. ACKRs are structurally similar to GPCRs but do not 
couple to G-proteins and therefore fail to induce the full spectrum of downstream 
intracellular signals that characterize GPCRs7,8. However ACKRs may transport, present or 
scavenge chemokines and thus, by different means, effectively regulate chemokine 
availability in tissue microenvironments9–12. The atypical chemokine receptor 1 (ACKR1), 
previously known as Duffy antigen receptor for chemokines or DARC, binds over 20 
different CC and CXC chemokines13,14 and has been ascribed a unique profile of cell 
expression in cerebellar neurons, venular endothelial cells and erythrocytes13,14. ACKR1 in 
endothelial cells transports and presents chemokines9. ACKR1 on erythrocytes was shown 
to regulate chemokine concentrations in plasma, acting as both chemokine sink and 
reservoir15–17 and to bind Plasmodium (P.) vivax and P. knowlesi, thus allowing their 
erythrocyte invasion18,19.
Divergent paths of human evolution and adaptations to geographically restricted microbial 
pathogens resulted in the development of distinctive functions of the immune system that 
characterize people of different ethnicities20,21. Under physiological conditions, individuals 
of African ancestry have low blood neutrophil counts22. Such “ethnic neutropenia” has been 
directly linked with the allelic variant rs2814778(G) of ACKR1 that is hugely prevalent in 
Africa, but the mechanism behind this association remained unexplored23. Individuals of 
African ancestry who are homozygous for the rs2814778(G) allele do not express ACKR1 
on erythrocytes24,25. This “Duffy-negative” phenotype is caused by one nucleotide 
substitution within the promoter of ACKR1, which disrupts the sequence binding the 
erythroid transcription factor GATA-1 and leads to the selective loss of ACKR1 expression 
in erythrocytes but not endothelium26,27. Erythrocytes are terminally differentiated anuclear 
cells with no transcription and limited translation28, suggesting that the expression of 
ACKR1 might occur first during the earlier stages of erythroid cell development in the bone 
marrow (BM). We therefore sought to determine ACKR1 expression in the BM, to 
investigate its impact on hematopoiesis and explore the mechanism leading to neutropenia in 
the absence of erythroid ACKR1.
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Results
ACKR1 is highly expressed by nucleated erythroid cells
We used a new specific monoclonal anti-mouse ACKR1 antibody29 to map ACKR1 
expression in mouse BM. Apart from the endothelial cells (ECs), which line BM sinusoids, 
ACKR1 expression was detected only on erythroid cells but not on any other hematopoietic 
population (Fig. 1a–c and Supplementary Fig.1 and Supplementary Fig.2). Nucleated 
erythroid cells (NECs) expressed ACKR1, initially in proerythroblasts, peaking in early 
normoblasts and gradually declining to the lowest expression in mature erythrocytes (Fig. 1c 
and Supplementary Fig. 2b). ACKR1 on NECs was functional. Fluorescently-labeled CCL2, 
an ACKR1-cognate chemokine, bound to NEC subpopulations proportionately to the levels 
of their ACKR1 expression (Fig.1d). Even after extended pre-incubation, almost all NEC-
bound CCL2 could be removed from binding by a heterologous chemokine CXCL1 (Fig. 
1d). ACKR1 is the only chemokine receptor, which binds both CCL2 and CXCL1. Thus, 
ACKR1 on NECs did not actively scavenge chemokines, which remained available on the 
cell surface. In summary, our data unequivocally showed that, among hematopoietic BM 
cells, ACKR1 is expressed in the erythroid lineage only. The high level of ACKR1 
expression and chemokine binding by NECs, as compared to mature erythrocytes, suggested 
that ACKR1 might play an important physiological role in the BM.
ACKR1 deficiency alters early hematopoiesis
To evaluate the contribution of ACKR1 expression to BM homeostasis, we compared 
parameters of hematopoiesis in ACKR1-deficient30 and wild-type mice. ACKR1 expression 
had no effect on the overall BM cellularity, number of erythroid cells, relative proportions of 
their individual subpopulations or any of the erythrocyte parameters in blood 
(Supplementary Fig. 3). However, ACKR1 expression had cell-extrinsic effects on the BM 
hematopoietic stem and progenitor cells (HSPCs). In the absence of ACKR1, the size of the 
lineage-negative (Lin–) Sca-1+ c-Kit+ cell (LSK) population decreased (Fig. 2a), 
accompanied by their reduced proliferation (Fig. 2b) and increased surface expression of 
CD34 (Fig. 2c). Major reduction was seen in the CD48– subpopulation of LSKs (Fig. 2d and 
Supplementary Fig. 4a). Furthermore, we observed shifts in the proportions of individual 
LSK CD48– subpopulations of ACKR1-deficient mice, as compared to their wild-type 
littermates (Fig. 2e,f). These included an increased relative proportion of hematopoietic stem 
cells (HSCs; Fig. 2e), although their overall numbers remained unaltered (Fig. 2f), as well as 
a relative and an absolute decrease of the CD150– Flt3– and CD150–Flt3+ multipotent 
progenitor cells (MPP) 1a and 1b (Fig. 2e,f). Furthermore, the size of the Lin–Sca-1–c-Kit+ 
myeloid progenitor cell (MPC) population was reduced in ACKR1-deficient BM (Fig. 2g), 
due to decrease in populations of CD34+ CD16/32+ granulocytic-monocytic progenitor 
(GMP) and CD34– CD16/32– megakaryocytic-erythroid progenitor (MEP) cells (Fig. 2h,i). 
Conversely, the proportions of CD34+ CD16/32– common myeloid progenitor (CMP) cells 
and LSK CD48+Flt3– (MMP2) cells increased in the ACKR1-deficient BM (Fig. 2h,i and 
Supplementary Fig. 4b-d), whereas the numbers of LSK CD48+ cells, lineage-restricted 
progenitor (LRP) cells and common lymphoid progenitor (CLP) cells remained unchanged 
(Supplementary Fig. 4b,d,e). Thus the absence of ACKR1 resulted in numeric changes and 
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shifts in equilibria of HSPC subpopulations and led to characteristic changes in the 
expression of their surface effector molecules.
ACKR1 deficiency changes HSPC transcriptome
Next, we asked whether ACKR1 expression also affected the transcriptional makeup of 
HSPCs. To this end, LSK and GMP cells of ACKR1-deficient and wild-type littermates 
were sorted by flow cytometry to virtual purity and their transcriptomes were compared 
using a gene expression microarray. The transcripts for the overwhelming majority of genes 
were indistinguishable in corresponding cell populations of ACKR1-deficient and wild-type 
mice (Supplementary Fig. 5a,b). Significant differences primarily included the upregulation 
of the same set of genes in both LSK and GMP cells of ACKR1-deficient mice (Fig. 3a and 
Supplementary Fig. 5c), with the majority of these transcripts ascribed as neutrophil- or 
myeloid-specific (Fig. 3b and Supplementary Fig. 5d). Some of the transcripts of neutrophil-
specific effector molecules, including those encoding cathelicidin, neutrophil granule protein 
and resistin-like molecule-γ, increased in GMPs from ACKR1-deficient BM a thousand-fold 
or more (Supplementary Fig. 5b), although upregulated genes represented only a part of the 
characteristic neutrophil transcriptome and excluded some classical neutrophil markers (Fig. 
3c). Thus, the absence of ACKR1 lead to an upregulation of a subset of neutrophil and other 
mature cell-specific transcripts in HSPCs, findings consistent with altered differentiation of 
HSPCs. Together with the observed numeric and surface molecule changes in HSPC subsets, 
these data indicated that ACKR1 expression massively impacted on the balanced BM 
homeostasis of HSPCs.
ACKR1 on bone marrow NECs affects HSPCs
In the BM ACKR1 is expressed by sinusoidal ECs and NECs. Vessels in the BM serve as a 
HSPC niche31–33, whereas NECs have not previously been shown to impact on HSPC 
homeostasis. To explore whether the HSPC changes observed in ACKR1-deficient mice 
were due to the lack of ACKR1 expression in ECs, NECs or both, HSPC parameters were 
recorded in reciprocal irradiation BM-chimeric wild-type and ACKR1-deficient mice. Mice 
in individual groups expressed ACKR1 in either hematopoietic or stromal compartments, or 
in both or were globally ACKR1-deficient (Supplementary Fig. 6a-c). The characteristic for 
the ACKR1-deficient mice shifts in the HSPC populations and changes in the expression of 
CD34 on LSK cells, were associated in chimeric mice, which lacked ACKR1 expression in 
hematopoietic but not stromal compartments (Fig. 4a-c and Supplementary Fig. 6d). These 
data clearly pinpointed ACKR1 expressed in erythroid cells as a regulator of HSPC 
homeostasis.
Next, we asked whether ACKR1 expressed by circulating erythrocytes or by BM NECs 
might impact on HSPCs. To this end, we created parabiotic wild-type and ACKR1-deficient 
mice, which shared a common blood circulation but maintained their distinct tissue 
microenvironments, including those in the BM (Supplementary Fig.6e). ACKR1 on wild-
type erythrocytes that are present within the common circulation restored the plasma 
concentrations of a cognate chemokine CCL2 in the blood sampled from the ACKR1-
deficient parabionts (Supplementary Fig.6f), but failed to affect the characteristic 
overexpression of CD34 and the disbalance of HSPC populations in their BM (Fig. 5a–c and 
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Supplementary Fig.6g). Collectively, our data on ACKR1 expression in BM together with 
the findings in reciprocal BM chimeric and parabiotic mice showed that ACKR1 expressed 
on BM NECs regulated in trans-geometry the homeostasis of HSPCs.
ACKR1 on NECs promotes direct cell interactions with HSCs
NECs are ubiquitous BM cells that might interact directly with the HSCs and thus affect 
their behavior. Two-photon microscopy of whole-mount BM preparations allowed 
unequivocal detection of NECs and HSCs (Supplementary Fig. 7a,b) and showed that NECs 
formed immediate contacts with the majority of HSCs present in the wild-type BM (Fig. 6a). 
ACKR1 facilitated the establishment of these close cell encounters, as in the ACKR1-
deficient BM only a third of all HSCs directly interacted with NECs (Fig. 6b), while their 
majority localized at a distance (Fig. 6c and Supplementary Fig. 7c). The direct interactions 
of HSCs and NECs were sufficiently avid to register as cell duplets in flow cytometry, 
revealing higher proportions of NEC-HSC duplets in wild-type versus ACKR1-deficient BM 
(Fig. 6d). Flow cytometry showed that MMP1, MPP2 and LRP also formed direct cell 
contacts with NECs, however only MMP1 and LRP, but not MPP2 required ACKR1 on 
NECs for their establishment (Supplementary Fig. 7d). These data uncovered the previously 
not recognized direct interactions of NECs and HSPCs and the unexpected role that ACKR1 
plays in their formation. Together with the observed impact of ACKR1 deficiency on 
HSPCs, our data suggest that NECs are directly involved in regulating the early stages of 
hematopoiesis and that ACKR1 deficiency in the erythroid lineage might broadly affect the 
phenotypes of BM-derived cells.
ACKR1 deficiency alters neutrophil phenotype
We used ACKR1-deficient mice to explore how the absence of ACKR1 in the erythroid 
lineage might affect neutrophils. Neutrophils that developed downstream of the altered 
HSPCs in the ACKR1-deficient BM, carried a characteristic molecular signature, most 
notably overexpression of Fcγ-receptors (FcγR; CD16/32), key molecules involved in 
neutrophil antimicrobial defenses34 and CD45, a molecule that amplifies FcγR function35, 
but not several other membrane receptors (Fig. 7a and Supplementary Fig. 8a,b). A similar 
phenotype characterized neutrophils of healthy Duffy-negative individuals homozygous for 
the rs2814778(G) ACKR1 allele, which in comparison to neutrophils of Duffy-positive 
individuals also selectively overexpressed FcγRIIIb (CD16) and CD45 (Fig. 7b). Moreover, 
neutrophils of both ACKR1-deficient mice and Duffy-negative individuals selectively 
overexpressed CCR2 (Fig. 7c,d and Supplementary Fig. 8c,d), a key inflammatory 
chemokine receptor that characterizes monocytes, rather than neutrophils1. Thus, HSPCs, 
altered in the absence of the erythroid ACKR1, gave rise to phenotypically distinct 
neutrophils, which overexpressed a set of membrane molecules involved in host defenses. 
The same set of membrane effector molecules was upregulated on neutrophils of Duffy-
negative individuals suggesting that the absence of erythroid ACKR1 due to rs2814778(G) 
allele might change BM homeostasis by the same mechanism as observed in ACKR1-
deficient mice.
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ACKR1 deficiency on NEC and its expression on EC cause neutropenia
Healthy Duffy-negative individuals of African ancestry have low blood neutrophil counts22. 
In contrast, ACKR1-deficient mice had normal neutrophil counts in blood (Fig. 8a) and BM 
(Supplementary Fig. 8e). Thus, the numeric reductions in the LSK subsets and GMPs 
observed in ACKR1-deficient mice did not directly lead to neutropenia. Also, ACKR1-
deficient mice had normal numbers of all other circulating cell types, despite some changes 
in the BM (Supplementary Fig. 8e–g). Importantly, Duffy-negative individuals homozygous 
for the rs2814778(G) allele lack ACKR1 on erythroid cells only, but still express ACKR1 on 
ECs. To explore whether such a pattern of ACKR1 expression might lead to neutropenia, we 
studied blood neutrophils in reciprocal wild-type and ACKR1-deficient BM chimeric mice. 
Wild-type mice reconstituted with ACKR1-deficient BM had characteristically altered 
neutrophils (Supplementary Fig. 8h) and were indeed neutropenic (Fig. 8b). This finding 
suggests that the expression of ACKR1 in the venular compartment contributes to 
neutropenia possibly, in line with its established function in ECs9,36, by facilitating 
neutrophil exit into the tissues. We explored this hypothesis and asked which tissues might 
clear the phenotypically altered neutrophils that develop in the absence of NEC ACKR1. 
Parabiotic wild-type and ACKR1-deficient mice allowed us to directly compare in one 
artificially created organism the homing of neutrophils of wild-type or ACKR1-deficient 
mice into individual ACKR1-sufficient or deficient tissues. Neutrophils that developed in 
ACKR1-deficient BM preferentially homed into spleens of the wild-type parabionts, but not 
other organs tested, which included BM, liver and lungs (Fig. 8c). In mouse spleen ECs of 
the red pulp sinusoids expressed ACKR1 (Fig. 8d) in direct accord with the expression of 
ACKR1 in human spleens (Supplementary Fig. 8i), including in Duffy-negative 
individuals27. It is not clear if altered neutrophils that migrate into spleen persist there and 
might contribute to the splenic host defenses. Alternatively, the EC ACKR1-dependent 
migratory step of neutrophils into the spleen might be part or their clearance from 
circulation, akin to the mechanism described for neutrophil homing into the BM37. Thus, 
we show that altered neutrophils, which develop in the absence of ACKR1 on NECs leave 
circulation causing neutropenia, but only when ACKR1 is expressed by venular ECs, a 
pattern of ACKR1 expression mirrored in individuals of African ancestry homozygous for 
the rs2814778(G) allele.
Discussion
Hematopoiesis is a robust process controlled by multiple molecular and cellular cues that 
maintain HSPCs and regulate their differentiation and proliferation for consistent BM cell 
outputs32,33. Here we show that ACKR1 expressed by NECs, the most ubiquitous BM 
cells, regulates the homeostasis of HSPCs and modifies downstream hematopoiesis. The 
absence of ACKR1 led to altered numbers of HSPCs, due, in part, to their decreased 
proliferation. It also resulted in shifts in proportions of individual HSPC subpopulations, 
changes in HSPC transcriptomes, and altered expression of their functional surface 
molecules. The overall BM cellularity was not affected by ACKR1 and the numeric changes 
in the individual subpopulations of HSPCs appeared incongruent. The number of HSCs, 
BM’s “reserve” population38,39, was not affected. However, the immediate downstream 
population, MPP1a, was reduced and MPP1b cells were practically absent from the ACKR1-
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deficient BM. This was accompanied by an increase in CMPs, a population downstream of 
MPP1, which might have resulted from accelerated differentiation from MPP1 to CMP. 
Alternatively, the numerically increased CMPs may have derived from MPP2 populations, 
which also increased in the ACKR1-deficient BM, suggesting either a potential contribution 
of alternative progenitor clones present in the BM40 or pathway plasticity of early HSPC 
differentiation41. It is possible that changes in expression of molecular markers that were 
used for definition of HSPCs subpopulations contributed to the numeric differences 
observed in the ACKR1-deficient BM.
Experiments in ACKR1-deficient chimeric and parabiotic mice unequivocally established 
that HSPCs were affected by ACKR1 on NECs, but not on the ECs or the circulating 
erythrocytes. Furthermore, the expression of ACKR1 by NECs increased direct cell contacts 
between HSPC populations and NECs. These data suggest that ACKR1 determines the 
function of a HSPCs niche associated with NECs, the existence of which has not been 
recognized previously. Currently it is not clear whether ACKR1 only mediates the 
interaction of NECs and HSPCs, but another putative NEC molecule signals to HSPCs. 
Alternatively, ACKR1 might directly signal to HSPCs, e.g. involving tetraspanin CD82, 
suggested to bind ACKR1 in trans-geometry42. Recently, CD82 on HSCs has been 
implicated in maintaining their quiescence through interaction with ACKR1, detected 
spuriously on BM macrophages using a non-validated antibody43. Indeed, high 
concentration of this antibody stained BM macrophages, albeit equally well in ACKR1-
deficient mice. Based on the immunostaining with a specific antibody and a transcriptome 
analysis, ACKR1 is not expressed on macrophages neither in the BM nor other tissues29. 
Nevertheless, it is possible that CD82, either in trans on HSPCs or through a cis interaction 
in NECs, might contribute to the effects of ACKR1 on HSPCs. Alternatively, the ACKR1-
dependent signal to HSPCs involves one or several of over 20 chemokine ligands of 
ACKR113. We showed that ACKR1 on NECs binds, but does not scavenge, cognate 
chemokines, thus potentially acts as a BM reservoir and a universal immobilization template 
for cognate chemokines. Such function might enable the retention of ACKR1 ligands in 
NEC-rich BM microenvironments thus allowing them to signal via GPCRs to HSPCs and 
other BM cells. The chemokine presentation template, ACKR1 on NECs, remains constant, 
but the signals to HSPCs might change depending on the individual chemokines 
immobilized and their endless potential combinations that characterize different 
physiological and pathological conditions. Several among ACKR1-cognate chemokines have 
been shown to affect HSPCs and hematopoiesis44, although CXCL12, which plays a key 
role in HSPC homeostasis45, does not bind ACKR146.
The absence of ACKR1 caused a shift in HSPC transcriptome, primarily massive 
overexpression of a subset of neutrophil- and myeloid-specific genes. This is consistent with 
altered differentiation of HSPCs towards the myeloid lineage and suggests that the 
characteristic molecular signature of neutrophils observed in ACKR1-deficiency might be 
imprinted already during the early steps of hematopoiesis. The signature changes in 
neutrophils that originated in the ACKR1-deficient BM were required, but not sufficient 
alone, to cause neutropenia. The BM chimeric mice showed that neutropenia developed only 
when the absence of BM ACKR1 was combined with the expression of ACKR1 in the 
venular ECs. Mechanistically this is in concert with the known contribution of ACKR1 on 
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ECs to optimal chemokine-driven neutrophil egress into the tissues9 and explains why 
globally ACKR1-deficient mice, despite generating altered neutrophils, were not 
neutropenic. Accordingly, in parabiosis experiments the emigration of the phenotypically 
altered neutrophils of the ACKR1-deficient parabionts took place preferentially into the 
spleens of wild-type mice. In addition to the spleen, venular ECs in several other organs and 
tissues, including the skin and the gut, but not the liver or the lungs, express ACKR129. 
Thus, neutrophils that develop in the absence of ACKR1 on NECs might also exit 
circulation, spleen apart, into the skin, gut and other tissues. BM sinusoids express ACKR1 
but did not support the preferential homing of altered neutrophils. This might be explained 
by neutrophils using an alternative chemokine pathway for their homing to the BM shown to 
involve CXCR4 and CXCL1237, not an ACKR1–cognate chemokine46.
The uncovered here peculiarities of hematopoiesis taking place in the absence of ACKR1 on 
NECs are highly relevant for human health as Duffy-negative individuals of African ancestry 
selectively lack ACKR1 expression in the erythroid lineage only, but express it in ECs25. 
Neutrophils of the Duffy-negative individuals mirror the distinct molecular signature of 
neutrophils in ACKR1-deficient mice. We suggest that these altered neutrophils also readily 
leave circulation thus leading to neutropenia associated with the rs2814778(G) ACKR1 
polymorphism23. It is conceivable that the differential signature of molecular effectors on 
neutrophils provided Duffy-negative individuals with a natural selective advantage for 
superior innate responses to microbial pathogens. Selective pressure by a broad range of 
infectious diseases, together with the known partial resistance of Duffy-negative individuals 
to P. vivax malaria47,48, may have contributed to the selection and fixation of the 
rs2814778(G) ACKR1 polymorphism in virtually entire population of Sub-Saharan 
Africa25.
In summary, we show that the absence of erythroid ACKR1 changes the steady-state 
hematopoiesis and alternative physiological patterns of hematopoiesis exist depending on 
ACKR1 expression in the erythroid lineage. In the future it will be intriguing to elucidate 
how ACKR1 expression by NECs might impact on emergency hematopoiesis and BM 
responses in infection, inflammation, injury and cancer.
Online Methods
Mice
ACKR1-deficient mice (Ref. 30) were backcrossed for more than 12 generations onto a 
C57BL/6J background and maintained as a heterozygous breed. Wild-type and ACKR1-
deficient littermates were used for comparative studies. Mice were housed in specific 
pathogen-free facilities at the Universities of Birmingham and York, UK, LMU Munich, 
Germany, BMWF, Austria and CNIC, Madrid, Spain. All experimental procedures were 
performed with 8–12-week-old female mice, as approved by the respective Institutional 
Ethics and Animal Welfare Committees, Home Office, UK, or Regierung von Oberbayern, 
Munich, Germany, and compliant with UK, German, Spanish, Austrian and European Union 
guidelines.
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Immunofluorescence staining and detection of ACKR1
Femurs were collected, cleaned and both ends cut off to facilitate the fixation in PFA (4%) 
overnight at 4°C. Bones were washed and decalcified in PBS with EDTA (10%) for 3 days, 
washed and incubated in 20% sucrose PBS overnight at 4°C, and finally embedded in OCT 
and stored at –80 °C. Sections (7 μm) were cut and blocked in 20% goat serum plus 0.5% 
Triton X-100 in PBS for 30 min at 20°C. After washing, sections were stained with rat anti-
mouse CD31 antibody in PBS with 0.1% BSA, and secondary goat anti-rat AF488 was 
added. Finally, sections were stained with directly conjugated antibodies to mouse Ter119 
(AF647) and mouse ACKR1 (AF546) for 1 h and washed with PBS. Slides were mounted in 
ProLong Gold anti-fade with DAPI for imaging. Evaluation was performed on a LSM880 
(Zeiss).
Spleens were frozen in OCT on dry ice and 7 μm sections were cut on a cryomicrotome. 
Before staining, slides were air-dried for 30 min and fixed in acetone for 10 min. Slides were 
washed in PBS shortly and subsequently blocking with 20% goat serum in 0.1%BSA/PBS 
was performed. Antibodies against DARC (AF546), MECA-32 (AF647) and Ter119 (FITC) 
were diluted in 0.1% BSA in PBS and incubated on slides for 60 min. After three washes in 
PBS, slides were dipped in dH2O, mounted with Prolong Gold with DAPI and evaluated as 
above.
Flow cytometry
To obtain BM cells, femurs were flushed with PBS and cells were washed with FACS buffer 
(PBS with 0.5% BSA). Fc receptors were blocked by rat antibody to mouse CD16/CD32 
(2.4G2; BD Bioscience), where appropriate. In all experiments, antibody staining was 
performed at 4 °C for 60 min. Cells were counted using CountBright Absolute Counting 
Beads (Life Technologies), and were analyzed using a FACS CANTOII or LSR Fortessa 
flow cytometers (BD Biosciences) and FlowJo software (TreeStar). Details regarding 
antibodies used in flow cytometry and immunofluorescence staining are provided in 
Supplementary Table 1.
ACKR1 expression in BM cells
NECs were stained with antibodies to CD71 and Ter119. Stages of erythropoiesis were 
defined as follows: CD71hi Ter119int (population I, proerythroblasts), CD71hi Ter119hi 
forward scatter (Fsc)hi (population II, early normoblast), CD71hi Ter119hi Fscint/lo 
(population III, intermediate normoblasts), CD71hi/int Ter119hi Fsclo (population IV, late 
normoblasts), CD71int Ter119hi Fsclo (population V, reticulocytes) and CD71lo Ter119hi 
Fsclo (population VI, mature erythrocytes). Fig. 1b provides details of the gating strategy. In 
addition, BM leukocytes were gated as Lineage (CD11b, Gr1, CD3, B220)+ CD71– Ter119– 
cells. HSPCs were stained as described below. Expression of ACKR1 in NECs, leukocytes 
and HSPC was determined using the monoclonal anti-mouse ACKR1 antibody. ACKR1 
expression was calculated in each erythoid cell population as specific delta mean 
fluorescence intensity (ΔMFI) = MFI in wild-type mouse minus average MFI in KO group. 
Data were then normalized to MEP and expressed as fold change.
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HSPC analysis
For HSPC analysis, BM cells were stained with combinations of antibodies to the following 
surface markers: c-Kit, Sca-1, CD150, CD48, Flt3, CD34, CD16/32, IL-7ra and the lineage 
markers Ter119, B220, CD3, CD11b and Gr1. HSPCs were defined as follows:
HSC (Lineage– Sca1+c-Kit+CD48–CD150+Flt3–);
MPP1a (Lineage– Sca1+ c-Kit+ CD48– CD150– Flt3–);
MPP1b (Lineage– Sca1+ c-Kit+ CD48– CD150– Flt3+);
MPP2 (Lineage– Sca1+c-Kit+CD48+CD150+Flt3–);
LRP1 (Lineage– Sca1+c-Kit+CD48+CD150–Flt3–);
LRP2 (Lineage– Sca1+c-Kit+CD48+CD150–Flt3+);
CMP (Lineage– Sca1–c-Kit+CD34+ CD16/32–);
GMP (Lineage– Sca1–c-Kit+CD34+ CD16/32+);
MEP (Lineage– Sca1–c-Kit+CD34– CD16/32–) and
CLP (Lineage– Sca1lo c-Kitlo IL-7ra+ Flt3+).
Neutrophil analysis
For surface markers and chemokine receptors expression analysis on neutrophils, BM cells 
were collected as above and blood cells were obtained by cardiac puncture in EDTA as an 
anticoagulant. Erythrocytes were lysed using ACK lysing buffer and cells washed with 
FACS buffer. Cells were reacted with antibodies to CD45, CD11b, Ly6G, CD16/32, CD62L, 
CD11a, CXCR2, CCR1, CCR2, CCR3 and CCR5.
Chemokine binding assay
BM cells were incubated with A647-conjugated CCL2 (10 nM, Almac) for 1 h at 37 °C and 
some cells were subsequently incubated with an excess of CXCL1 (1 µM) in PBS for 1 h to 
displace CCL2 or PBS alone. Cells were washed, stained for NEC markers using antibodies 
to CD71 and Ter119, and analyzed by flow cytometry. Specific binding of CCL2 was 
calculated for individual erythroid cell populations as ΔMFI of CCL2-A647 in wild-type and 
KO groups, normalized for the ACKR1-KO mature erythrocytes (population VI) and 
expressed as fold change.
Analysis of HSC-NEC interactions by flow cytometry
For observations of HSC-NEC interaction, mice were euthanized and perfused with PFA via 
cardiac route in order to fix the cells in situ and preserve their interactions. BM cells were 
collected and stained with the following antibody panel: c-Kit, Sca-1, CD150, CD48, CD71 
and Ter119 and the lineage markers B220, CD3, CD11b and Gr1. The HSCs (LSK 
CD48–CD150+), MPP1 (LSK CD48– CD150–), MPP2 (LSK CD48+CD150+) and LRP 
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(LSK CD48+ CD150–) were gated and their interaction with NECs was assessed by the 
presence of costaining with CD71 and Ter119 on the duplets.
Blood erythrocyte and BM NEC parameters
Blood was taken by cardiac puncture and erythrocyte counts, hematocrit and hemoglobin 
concentration were determined using an automated ABX Pentra 60 blood counter (HORIBA 
ABX S.A.S). For BM analysis, mice were culled and flushed with PBS to remove 
erythrocytes present within the blood vessels. BM was harvested and different stages of 
erythropoiesis were analyzed as above.
Cell parameters in BM and blood
For BM leukocyte analysis the cells were stained with combinations of antibodies to the 
following surface markers: CD11b, Ly6G, CD115, CD19, B220. Leukocyte populations 
were defined as follows:
PMN (CD11b+Ly6G+);
Monocytes (CD11b+Ly6G– CD115+);
B lineage (B220+CD19–).
Blood was taken by cardiac puncture and platelet counts were determined using an 
automated ABX Pentra 60 blood counter (HORIBA ABX S.A.S.). In addition, erythrocytes 
were lysed using ACK lysing buffer and cells washed with FACS buffer. Cells were reacted 
with antibodies to CD45, CD11b, Ly6G, CD115, CD3 and B220. Leucocyte populations 
were defined as follows:
PMN (CD11b+Ly6G+);
Monocytes (CD11b+Ly6G–CD115+);
Lymphoid cells (B220+ CD3+).
Cell proliferation
To assess the proliferation of BM cell populations, the APC BrdU flow kit (BD Bioscience) 
was used as per the manufacturer’s instructions. Briefly, 5-bromo-2′ deoxyuridine (BrdU) 
was injected i.p. (1 mg) into wild-type and ACKR1-deficient mice. After 2 h, mice were 
euthanized, BM collected and labeled with a cocktail of biotinylated lineage antibodies 
followed by labeling with Anti-Biotin MicroBeads (Miltenyi Biotec) as per the 
manufacturer’s instructions. Lineage+ BM cells were depleted and lineage– BM cells were 
incubated with streptavidin (e450, eBioscience,) and with fluorescently labeled antibodies to 
c-Kit and Sca-1 for 1 h on ice. Cells were washed, fixed, permeabilized, stained with anti-
BrdU antibody and analyzed by flow cytometry.
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Reciprocal irradiation BM chimeric mice
BM cells from either C57BL/6 (wild-type) or ACKR1-deficient mice (KO) were harvested 
and transplanted into lethally irradiated (9 Gy) wild-type or ACKR1-deficient recipients by 
tail vein injection of 107 cells in 200 μl PBS, thus creating four experimental groups. 
Recipients received prophylactic endofloxacin (Baytril, Bayer AG) for a week prior to and 
also after irradiation. Eight weeks after the BM transfer the recipients were culled. BM and 
blood cells were collected, washed and stained to identify HSPCs and PMNs, respectively, 
as described above. The degree of donor chimerism was established by measuring the 
expression of ACKR1 on BM NECs and blood erythrocytes using anti-mouse ACKR1 
antibody. In addition, CD45.1 and CD45.2 staining showed that all irradiated recipients BM 
HSPCs and blood PMNs were replaced by donor cells.
Parabiosis
To generate parabiotic pairs, we followed published protocols (49). Briefly, anesthetized 
mice were shaved at the corresponding lateral aspects and matching skin incisions were 
made from the olecranon to the knee joint of each mouse, and the subcutaneous fascia was 
bluntly dissected to create about 0.5 cm of free skin. The olecranon and knee joints were 
attached by a single 5-0 polypropylene suture and tie, and the dorsal and ventral skins were 
approximated by continuous suture. A single dose of flunixin meglumine (Schering-Plough) 
was injected subcutaneously in each partner at the end of the surgical procedure (1 mg/kg). 
Wild-type/wild type, KO/KO and wild-type/KO pairs were created. One month after surgery 
blood and BM were obtained from each of the partners for analysis of hematopoietic 
progenitors.
In another experiment where the homing of neutrophils was studied, different parabiotic 
pairs were undertaken: wild-type/wild type pairs (CD45.1 and CD45.2) and wild-type/KO 
pairs (CD45.1 and CD45.2 respectively). One month after surgery, blood, BM, spleen, lung 
and liver samples were obtained from each of the partners for analysis of neutrophils. 
Percentage of neutrophils from partner parabionts (percent chimerism) was defined on gated 
neutrophils in blood, BM, lung, liver and spleen. Migration indices were calculated for each 
tissue as the percent chimerism in a specific tissue divided by the percent chimerism in 
blood and normalised by using the values obtained in wild-type/wild type control pairs.
Cell sorting
BM of wild-type or ACKR1-deficient mice was flushed, cells were pooled from three mice 
and stained with lineage CD34, CD16/CD32, cKit, Sca-1 in 500 μl buffer, for 1 h on ice. 
Cells were sorted on a Mo-flow MultiLaser flow cytometer (Beckman Coulter). First, an 
enrichment step was performed, with gates set based on forward- and side- scatter 
characteristics for lineage-negative and either GMP cells or LSK cells. The GMP and LSK 
populations then underwent a second sorting step using the same gating profiles. The twice-
sorted GMP and LSK populations, determined to be more than 97% pure, were snap frozen 
on dry ice for storage at -80 °C until used.
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Microarray and analysis
RNA was extracted from sorted GMP and LSK populations using Trizol (Life Technologies) 
as per manufacturer’s directions. Sample RNA (25 ng) was labelled with Cy3 dye as per the 
protocol detailed in the Low Input Quick Amp Labelling Kit (Agilent Technologies). A 
specific activity of greater than 6.0 was confirmed by measurement of 260 nm and 550 nm 
wavelengths with a NanoDrop ND-1000 Spectrophotometer. Labelled RNA (600 ng) was 
hybridized for 16 h to Agilent SurePrint G3 mouse 8x60K microarray slides. Slides were 
washed and scanned with a High Resolution C Scanner (Agilent Technologies), using a scan 
resolution of 3 μm. Feature extraction was performed using Agilent Feature Extraction 
Software, with no background subtraction. Scanned microarray images were analyzed using 
Agilent’s Feature Extraction software. Feature intensities were background-subtracted 
according to the normal-exponential convolution model and normalized using 75th percentile 
normalization. Differentially expressed genes were identified using Significant Analysis of 
Microarrays (SAM) method with FDR<0.05 using Multiexperiment Viewer (MeV) software 
(http://www.tm4.org/mev.html). Hierarchical clustering was obtained using Gene Cluster3.0 
software.
In order to ascribe characteristic profiles to the set of genes differentially expressed in the 
microarray analysis, the specificity of genes upregulated in both LSK and GMP from KO 
mice, defined as Cluster 1, was determined based on their annotation in Gene Expression 
Commons (GEXC) (50). Briefly, the gene expression activity files of all BM cells were 
downloaded from GEXC (https://gexc.stanford.edu), aligned with the retrieved 69 genes of 
Cluster 1 and the heatmaps of their expression activity were created for individual cell 
populations. The analysis showed enrichment primarily in PMN-specific genes. To 
determine whether such enrichment was selective for a subset or PMN genes, the expression 
of all genes annotated as PMN-specific in the Immgen database (http://www.immgen.org/) 
was assessed in the microarray. Briefly, among 334 defined cell-specific clusters in Immgen 
“Modules and Regulators” tool, three modules 209, 210 and 258 have been assigned as 
PMN-specific, encompassing 54 genes in total, 22, 11 and 12, respectively. The expression 
of these genes was verified in the microarray and presented for individual modules as 
heatmaps.
Two-photon laser scanning microscopy (TPLSM) of the whole mounted BM
Mice were euthanized and perfused via cardiac puncture with 3 ml cold PBS followed by 3 
ml cold 4% paraformaldehyde (PFA). Femurs were harvested, carefully cleaned from the 
surrounding tissue and post-fixed in 4% PFA at 4°C overnight. After fixation, bones were 
shortly washed with PBS and cryopreserved in 15% sucrose at 4 °C for 2 h followed by 
incubation in 30% sucrose at 4 °C overnight. Bones were embedded into Optical Cutting 
Temperature (OCT) compound and flash-frozen. Samples were longitudinally shaved with a 
Leica CM3050S cryostat in order to expose the BM along the full femur length, OCT 
residues were washed away with PBS and non-specific antigens were blocked by a PBS 
solution containing 20% normal goat serum and CD16/CD32 Fc-block (final concentration 
0.5 μg/ml) for 2 h at 20°C Bones were incubated overnight in the dark at 20°C with the 
following directly-conjugated antibodies: CD150, CD71 and Lineage (CD3, B22, Gr1, 
CD11b, CD48, CD41). After incubation, the bones were washed several times with PBS and 
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embedded into PBS-based 1.5% agarose gel prior to imaging. Further details regarding 
imaging reagents are provided in Supplementary Table 1.
Four-color TPLSM microscopy was performed on a Leica SP5IIMP equipped with a 20X 
NA1.00 WD objective (Leica) and a pre-chirped MaiTai Ti:Sa pulsed laser (Spectra-Physics) 
tuned at 800 nm to maximize dye emission. Optical zoom was applied where applicable. To 
allow the simultaneous collection of all spectra while minimizing color spillover, the 
collection channels of Hybrid diode detectors were determined as follows: 380-415 nm for 
bone-collagen-derived SHG signal, 420-470 nm for Pacific Blue, 500-550 nm for Alexa 
Fluor 488 and 600-650 nm for PE. z-stacks (1 μm step-size) of 1024x1024 pixel xy images 
(f.o.v. 356 x 356 μm2) were collected up to 100-150 μm depth. z-stacks were 3D 
reconstructed using the Imaris software (Bitplane). HSCs were identified as 
CD150+Lin–CD7– cells and NECs as CD71+Lin–CD150– cells. Both stains were rendered as 
isosurface and distances between HSCs and the closest NECs were determined using the 
software’s measurement tools.
Human population genetics
Allele frequencies for the autosomal SNP rs2814778 within different ethnic populations 
were retrieved from 1000 genomes project dataset using Ensembl (www.ensembl.org). The 
A and G alleles correspond to the adenine and guanine, respectively, at the position -43 
within GATA-1-binding motif of the promoter of ACKR1 gene. Substitution from A to G 
results in the absence of ACKR1 expression in the erythroid lineage.
Human blood samples
Blood was collected from healthy individuals as approved by the ethical committee of LMU, 
Munich following written consent. To determine the expression of Duffy antigen on 
erythrocytes the whole blood was stained with mouse monoclonal anti-ACKR1 antibody 
(Fy6, gift from Dr. M. Uchikawa), washed and stained with a FITC-conjugated secondary 
antibody. For staining of neutrophil surface markers erythrocytes were lysed using ACK 
lysing buffer and cells washed with FACS buffer. Cells were reacted with antibodies to 
CD45, CD11b, CD16, CXCR1, CXCR2 and CCR2 analyzed using a FACS CANTO II flow 
cytometer.
Statistical analysis
Multiple independent experiments were performed to verify the reproducibility of 
experimental findings. When suitable, sample sizes were estimated based on results of 
explorative experiments in order to provide adequate power. No randomization or blinding 
was used in any experiments. Animals were excluded from experiments if they showed any 
signs of sickness. Differences in two group comparisons were assessed by unpaired 
Student’s t-test, with Welch’s correction when appropriate. Comparisons between three or 
more group were performed by One-Way or Two-Way ANOVA as appropriate, followed by 
Tukey’s post-hoc test. Difference in proportions was assessed by χ2 with Fisher’s 
correction, when appropriate. Statistical significance is represented by asterisks and 
corresponding p=values as indicated in the legends. Data are expressed as mean values ± 
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SEM or mean values ± SD. Biological replicates are stated in the legends for each figure. 
Statistical analysis was performed with G-Power (51) and Prism6 (GraphPad) softwares.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. ACKR1 is expressed in the BM by ECs and NECs.
(a) Immunofluorescence micrograph of wild-type BM stained with anti-ACKR1 (yellow), 
anti-Ter119 (red, erythroid cells) and DAPI (blue). Insets show ACKR1 immunoreactivity in 
sinusoidal EC (arrows), anuclear mature erythrocytes (arrowheads) and NECs (asterisks). 
Scale bars, 30 μm (main image) and 15 μm (insets). (b) BM flow cytometry to identify the 
stages of erythroid maturation; proerythroblasts (I), early normoblasts (II), intermediate 
normoblasts (III), late normoblasts (IV), reticulocytes (V) and mature red cells (VI) gated 
based on CD71, Ter119 and forward scatter (Fsc). (c) ACKR1 expression on 
megakaryocytic-erythroid progenitors (MEP) and erythroid cells (I-VI) in wild-type (blue) 
and ACKR1-deficient (red) BM. Left, representative flow cytometry histogram plots; right, 
quantitative analysis in wild-type BM expressed as fold change to MEP. Mean±SEM; n=6 
from two independent experiments. One-way ANOVA; ***P < 0.01. (d) AF647-CCL2 
binding to erythroid cells (I-VI) isolated from wild-type (blue) and ACKR1-deficient (red) 
BM and competition for AF647-CCL2 binding to wild-type erythroid cells by subsequent 
addition of unlabeled CXCL1 (grey). Top, representative flow cytometry histogram plots; 
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bottom, quantitative analysis expressed as fold change compared to binding to ACKR1-
deficient erythrocytes. Mean±SD; n=2 from two independent experiments. Two-way 
ANOVA, * P<0.05, **P < 0.01, ***P < 0.001
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Fig. 2. ACKR1 deficiency alters HSPC populations.
(a) Frequency of LSKs in wild-type (WT; blue) and ACKR1-deficient (KO; red) BMs, (b) 
BrdU incorporation and (c) CD34 expression in LSK cells. (d) Frequency of LSK CD48– 
cells and (e) relative distribution of their HSC, MPP1a and MPP1b subpopulations. (f) BM 
frequencies of HSC, MPP1a and MPP1b cells. (g) Frequency of MPCs and (h) distribution 
of their CMP, GMP and MEP subpopulations. (I) BM frequencies of CMP, GMP and MEP 
cells. (a, c-f) n=12 in four independent experiments. (b) n= 8 in two independent 
experiments. (g-i) n=9 in three independent experiments. All data show Mean±SEM. Two-
tailed Student’s t-test; *P < 0.05, **P < 0.01 and ***P < 0.001.
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Fig. 3. ACKR1 deficiency changes HSPC transcriptomes.
(a) Microarray heatmap of gene expression in LSK and GMP populations from wild-type 
(WT) and ACKR1-deficient (KO) BM. (b) Genes from cluster 1 were analyzed for their 
expression activity in different BM cell types. Erythroid cells (Ery); Megakaryocyte 
progenitors (MkP); Neutrophils (Neu); Monocytes (Mo); B cell progenitors (proB); mature 
B cells (B); natural killer (NK); T cell progenitors (proT) and T cells (T). (l) Microarray 
heatmaps showing gene expression in three specific neutrophil-enriched modules. Black 
boxes indicate genes significantly upregulated in HSPC from AKCR1-deficient as compared 
to WT cells.
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Fig. 4. ACKR1 on erythroid cells but not ECs regulates HSPCs.
(a) CD34 expression in LSK cells of BM chimeric mice; wild-type (WT) reconstituted into 
WT (blue), WT reconstituted into ACKR1-deficient (KO, light blue), KO reconstituted into 
KO (red) and KO reconstituted into WT (pink). Left, representative flow cytometry 
histogram plots; right, quantitative analysis. (b-c) Proportions of HSC, MPP1a and MPP1b 
subpopulations of LSK CD48– cells (b) and CMP, GMP and MEP subpopulations of MPCs 
(c) in BM chimeric mice; Left, representative dot plots; right, quantitative analysis. . n=4 
from two independent experiments. One-way ANOVA. All data are Mean±SEM., *P < 0.01 
and **P < 0.001.
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Fig. 5. ACKR1 on BM erythroid cells regulates HSPC.
(a) CD34 expression by LSK in parabiotic mice: wild-type (WT) with WT (blue), ACKR1-
deficient (KO) with KO (red), WT in WT with KO parabiotic pair (purple) and KO in WT 
with KO parabiotic pair (orange). Left, representative flow cytometry histogram plots; right, 
quantitative analysis. (b-c) Proportions of HSC, MPP1a and MPP1b subpopulations of LSK 
CD48– cells (b) and CMP, GMP and MEP subpopulations of MPCs (c) in BMs of parabiotic 
mice; Left, representative dot plots; right, quantitative analysis. n=4 from two independent 
experiments. One-way ANOVA. All data are Mean±SEM. *P < 0.05, **P < 0.01 and ***P < 
0.001.
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Fig. 6. ACKR1 on NECs promotes direct cell interactions with HSCs.
(a) BM localization of HSCs (blue) and NECs (red) in representative 3D-recontruction 
images from wild-type (WT) and ACKR1-deficient (KO) whole-mounted femurs assessed 
by two-photon microscopy. White squares with Arabic numerals mark cell contacts between 
a HSC and NECs; yellow squares with Roman numerals indicate HSCs not interacting with 
NECs. Scale bars, 50μm (main images) and 25μm (insets). (b) Proportions of NEC-
interacting and non-interacting HSCs. Chi2 ; P < 0.0001. (c) Distance between HSCs and 
NECs in WT (blue) and KO (red) BM. Among non-interacting HSCs, distribution quartiles 
were defined as: Q1, < 2.56μm, Q2, < 4.96μm, Q3, < 8.30μm and Q4, <19.82μm. Mean±SD. 
One-way ANOVA. (b and c) n=145 HSCs (WT) and 144 HSCs (KO) assessed by two-
photon microscopy in two independent experiments. (d) HSC interactions with NECs (NEC-
HSC) assessed by flow cytometry in wild-type (WT) and ACKR1-deficient (KO); left, 
representative dot-plots; right, quantitative analysis. Two-tailed Student’s t-test, (n=3). Mean
±SEM. *P < 0.05, **P < 0.01 and ***P < 0.001.
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Fig. 7. Lack of ACKR1 affects neutrophil phenotype.
(a) Expression of CD16/32, CD45 and CD11b in blood neutrophils from wild-type (WT, 
blue) and ACKR1-deficient (KO, red) mice. n=9 from three independent experiments. (b) 
CD16, CD45 and CD11b expression in human blood neutrophils from healthy Duffy-
positive (grey bars, n=14) and Duffy-negative (black bars, n=7) individuals from three 
independent experiments. (c) Expression of CCR2 in blood neutrophils from WT and KO 
mice. n=9 from four independent experiments. (d) Expression of CCR2 in human blood 
neutrophils from Duffy-positive (n=11) and Duffy-negative individuals (n=4) in three 
independent experiments. All data show Mean±SEM. two-tailed Student’s t-test; *P < 0.01, 
**P < 0.001.
Duchene et al. Page 25
Nat Immunol. Author manuscript; available in PMC 2017 November 29.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Fig. 8. Lack of ACKR1 on NECs and its expression on EC causes neutropenia.
(a) Blood neutrophil counts in wild-type (WT, blue) and ACKR1-deficient (KO, red) mice; 
n=12 from three independent experiments. (b) Blood neutrophil counts in reciprocal BM 
chimeric mice. n=10 from two independent experiments. WT reconstituted into WT (blue), 
WT reconstituted into KO (light blue), KO reconstituted into KO (red) and KO reconstituted 
into WT (pink). (c) Reciprocal homing of neutrophils of WT (purple) and KO (orange) mice 
into BM, liver, lungs and spleen of their respective KO and WT parabionts (n=5) compared 
to WT neutrophil homing into the organs of WT parabionts (white; n=8). (d) Representative 
immunofluorescence micrograph of WT mouse spleen stained with anti-ACKR1 (red) and 
anti-MECA32 (blue; ECs) and anti-Ter119 (yellow; erythrocytes). Insets show ACKR1 
immunoreactivity in sinusoidal ECs. Scale bars, 50μm (main images) and 25μm (insets). All 
numeric data are Mean±SEM in dot-plots (a,b). For box plots (c), center lines represent the 
median; limits represent quartiles; whiskers represent minimum and maximum values. (a) 
two-tailed Student’s t-test; (b and c) One-way ANOVA; *P < 0.05, **P < 0.01, ***P < 
0.001.
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